Chemometric technique for the optimization of chromatographic system: Simultaneous HPLC determination of Rosuvastatin, Telmisartan, Ezetimibe and Atorvastatin used in combined cardiovascular therapy

Arabian Journal of Chemistry

Volumn 9, Issue , 2016, Pages S1378-S1387

  Sree Janardhanan, V ^a   Manavalan, R ^a   Valliappan, K ^a  

^a ANNAMALAI UNIVERSITY   (India)

Author keywords

Atorvastatin; Central composite design; Derringer's desirability function; Ezetimibe; Rosuvastatin; Telmisartan

Indexed keywords

CHROMATOGRAPHIC ANALYSIS; CHROMATOGRAPHY; PARTICLE SIZE; SURFACE PROPERTIES;

ATORVASTATIN; CENTRAL COMPOSITE DESIGNS; DERRINGER'S DESIRABILITY FUNCTION; EZETIMIBE; ROSUVASTATIN; TELMISARTAN;

QUALITY CONTROL;

EID: 84859188258     PISSN: 18785352     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.arabjc.2012.03.001     Document Type: Article

References (38)

1. Ballantyne, C.M., Houri, J., Notarbartolo, A., Melani, L., Lipka, L.J., Suresh, R.S., Sun LeBeaut, A.P., Sager, P.T., Veltri, E.P., Circulation 107 (2003), 2409–2415.
2. Beg, Q., Sahai, V., Gupta, R., Process Biochem. 39 (2003), 203–209.
3. Choisnard, L., Bigan, M., Blondeau, D., Dhulster, P., Leman, B., Guillochon, D., J. Appl. Polym. Sci. 89 (2003), 535–547.
4. Crowther, J.B., Ahuja, S., Scypinski, S., (eds.) Handbook of Modern Pharmaceutical Analysis, 2001, Academic Press, New York.
5. Danzer, K., Currie, L.A., Pure Appl. Chem. 70 (1998), 993–1014.
6. Davidson, M.H., McGarry, T., Bettis, R.L., Melani, L., Lipka, L.J., LeBeaut, A.P., Suresh, R., Sun, S., Veltri, E.P., J. Am. Coll. Cardiol. 40 (2002), 2125–2134.
7. Deming, S.N., J. Chromatogr. 550 (1991), 15–25.
8. Derringer, G., Suich, R., J. Qual. Technol. 12 (1980), 214–219.
9. Hadjmohammadi, M.R., Safa, F., J. Sep. Sci. 27 (2004), 997–1004.
10. Harrington, E.C., Ind. Qual. Control. 21 (1965), 494–498.
11. Hayashi, Y., Matsuda, R., Adv. Chromatogr. 34 (1994), 347–423.
12. International Conference on Harmonization, Q2A, 1995.60. Text on Validation of Analytical Procedures, Definitions and Terminology, US FDA Federal Register.
13. International Conference on Harmonization, Q2B, 1997.62. Validation of Analytical Procedures, Methodology, US FDA Federal Register.
14. Jones, P., Kafonek, S., Laurora, I., Hunninghake, D., Am. J. Cardiol. 81 (1998), 582–587.
15. Jones, P., Davidson, M., Stein, E., Bays, H., McKenney, J., Miller, E., Cain, V., Blasetto, J., Group, S., Am. J. Cardiol. 92 (2003), 152–160.
16. Kerzner, B., Corbelli, J., Sharp, S., Lipka, L.J., Melani, L., LeBeaut, A., Suresh, R., Mukhopadhyay, P., Veltri, E.P., Am. J. Cardiol. 91 (2003), 418–424.
17. Kleinschmidt, G., 2005. In: Ermer, J., Miller, J.H.M., (Eds.), Method Validation in Pharmaceutical Analysis. A Guide to Best Practice. Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim.
18. Kotani, A., Hayashi, Y., Matsuda, R., Kusu, F., Anal. Sci. 19 (2003), 865–869.
19. Lews, J.A., Snyder, L.R., Dolan, J.W., J. Chromatogr. A 721 (1996), 15–29.
20. Lui, Wai-Bun, Peng, B., J. Packag. Technol. Sci. 17 (2004), 295–305.
21. Lundstedt, T., Seifert, E., Abramo, L., Thelin, B., Nystrom, A., Pettersen, J., Bergman, R., Chemom. Intell. Lab. Syst. 42 (1998), 3–40.
22. Matthijs, N., Massart, D.L., Maftouh, M., Heyden, Y.V., 2004. In: Proceedings of the 15th International Symposium on Pharmaceutical and Biomedical Analysis. Florence, Italy.
23. McTaggart, F., Atherosclerosis Supp. 4 (2003), 9–14.
24. Melani, L., Mills, R., Hassman, D., Lipetz, R., Lipka, L., LeBeaut, A., Suresh, R., Mukhopadhyay, P., Veltri, E., Eur. Heart J. 24 (2003), 717–728.
25. Morgan, E., Chemometrics-Experimental Design. 1991, Wiley, Chichester.
26. Myers, R.H., Montgomery, D., Response Surface Methodology. 1995, John Wiley & Sons Inc., New York.
27. Neutel, J.M., Smith, D.H., Adv. Ther. 15 (1998), 206–217.
28. Parajo, J.C., Alonso, J.L., Lage, M.A., Vazquez, D., Bioprocess Eng. 8 (1992), 129–136.
29. Safa, F., Hadjmohammadi, M.R., J. Chromatogr. A 1078 (2005), 42–50.
30. Sivakumar, Thanikachalam, Manavalan, Rajappan, Muralidharan, Chandrashekaran, Valliappan, Kannappan, J. Sep. Sci. 30 (2007), 3143–3153.
31. Sivakumar, T., Manavalan, R., Valliappan, K., Acta Chromatogr. 19 (2007), 29–47.
32. Sivakumar, T., Manavalan, R., Muralidharan, C., Valliappan, K., J. Pharm. Biomed. Anal. 43 (2007), 1842–1848.
33. Sivakumar, Thanikachalam, Manavalan, Rajappan, Valliappan, Kannappan, J. Chromatogr. 67 (2008), 41–47.
34. Ting, H.T., Abou-El-Hossein, K.A., Chua, H.B., J. Sci. Ind. Res. 68 (2009), 920–924.
35. Valliappan, K., Kannan, K., Manavalan, R., Muralidharan, C., Ind. J. Chem. 41A (2002), 1334–1340.
36. Van Heek, M., France, C.F., Compton, D.S., Mcleod, R.L., Yumibe, N.P., Alton, E.J., Sybertz, K.B., Davis, H.R. Jr., Pharmacol. Exp. Ther. 283 (1997), 157–163.
37. Wang, Y., Harrison, M., Clark, B.J., J. Chromatogr. A 1105 (2006), 77–86.
38. Wang, Y., Harrison, M., Clark, B.J., J. Chromatogr. A 1105 (2006), 199–207.